Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma

Ombretta Melaiu(Bambino Gesù Children's Hospital), Marco Chierici(Fondazione Bruno Kessler), Valeria Lucarini(Bambino Gesù Children's Hospital), Giuseppe Jurman(Fondazione Bruno Kessler), Libenzio Adrian Conti(Bambino Gesù Children's Hospital), Rita De Vito(Bambino Gesù Children's Hospital), Renata Boldrini(Bambino Gesù Children's Hospital), Loredana Cifaldi(Bambino Gesù Children's Hospital), Aurora Castellano(Bambino Gesù Children's Hospital), Cesare Furlanello(Fondazione Bruno Kessler), Vincenzo Barnaba(Istituto Pasteur), Franco Locatelli(Bambino Gesù Children's Hospital), Doriana Fruci(Bambino Gesù Children's Hospital)
Nature Communications
November 25, 2020
Cited by 175Open Access
Full Text

Abstract

Tumor-infiltrating lymphocytes play an essential role in improving clinical outcome of neuroblastoma (NB) patients, but their relationship with other tumor-infiltrating immune cells in the T cell-inflamed tumors remains poorly investigated. Here we show that dendritic cells (DCs) and natural killer (NK) cells are positively correlated with T-cell infiltration in human NB, both at transcriptional and protein levels, and associate with a favorable prognosis. Multiplex imaging displays DC/NK/T cell conjugates in the tumor microenvironment of low-risk NB. Remarkably, this connection is further strengthened by the identification of gene signatures related to DCs and NK cells able to predict survival of NB patients and strongly correlate with the expression of PD-1 and PD-L1. In summary, our findings unveil a key prognostic role of DCs and NK cells and indicate their related gene signatures as promising tools for the identification of clinical biomarkers to better define risk stratification and survival of NB patients.


Related Papers

No related papers found

Powered by citation graph analysis